pembrolizumab,atezolizumab
merck,roche
['pembro', 'atezo', 'imvigor130', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', ' uc,(-ucsd),(-ucsf),']
a takeover of for onclive imvigor130: atezo/chemo vs chemo final os results in 1st line uc. while it was a statistical near miss for the combo there appears some antagonist. no practice changing. ev/pembrolizumab could change everything. #gu23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.